HIT Consultant

MAY 9, 2023

For any practitioner-patient telemedicine relationships that have been or will be established up to November 11, 2023, the full set of telemedicine flexibilities regarding the prescription of controlled medications established during the COVID-19 PHE will be extended for one year – through November 11, 2024.

COVID-19 98

COVID-19 Telemedicine Public Health Health Services Administration 98

Hall Render

MAY 9, 2023

Notably, the Temporary Rule, which can be accessed here , extends the COVID-19 PHE telemedicine flexibilities (hereinafter, “telemedicine flexibilities”) for six months following the end of the PHE (through November 11, 2023).

COVID-19 40

COVID-19 Telemedicine Health Services Administration Public Health 40

Healthcare IT News - Telehealth

MAY 10, 2023

Department of Health and Human Services said it would temporarily extend telemedicine flexibilities for the prescription of certain controlled medications granted under the COVID-19 Public Health Emergency, which is set to expire on May 11. This past week, the U.S. Drug Enforcement Agency and the U.S.

Telemedicine 119

Telemedicine COVID-19 Health Services Administration Public Health 119

Healthcare Law Blog

OCTOBER 17, 2023

Under the Second Temporary Rule, practitioners may continue to prescribe schedule II-V controlled medications via telemedicine for new and existing patients without conducting a prior in-person medical evaluation through 2024.

Telemedicine 52

Telemedicine COVID-19 Health Services Administration Public Health 52

Health Law Advisor

MARCH 7, 2023

The proposed rules are more restrictive than the DEA emergency waivers under which providers conducted telemedicine prescribing for the last three years, but are less restrictive in comparison to the pre-PHE regulations applicable to telemedicine prescribing of controlled substances under the federal Controlled Substances Act (“CSA”).

Telemedicine 52

Telemedicine COVID-19 FDA Compliance 52

Bill of Health

NOVEMBER 15, 2023

To access the additional 34 opportunities for improved health care for people with OUD and to learn more about the rationale behind these opportunities, visit [link] The Federal Government: “ The Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) moved too slowly in allowing mainstream (..)

Governance 174

Governance Public Health Telemedicine COVID-19 174

Healthcare Law Today

JANUARY 13, 2023

On January 12, 2023, the Drug Enforcement Administration (DEA) confirmed in a letter to registrants that the Consolidated Appropriations Act of 2023 (P.L. The Substance Abuse and Mental Health Services Administration (SAMHSA) also issued a statement on its website on the removal of the DATA-Waiver. What this Means.

COVID-19 114

COVID-19 Health Services Administration Telemedicine Licensing 114